Wells Fargo & Company Upgrades Voyager Therapeutics (NASDAQ:VYGR) to “Overweight”
Wells Fargo & Company upgraded shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) from an equal weight rating to an overweight rating in a research note issued to investors on Tuesday, MarketBeat reports. The firm currently has $14.00 price target on the stock, up from their previous price target of $9.00. Other research analysts also […]
More Stories
Retail Sales Jumped 1.4 Percent in March Amid Rush to Beat Tariffs
By Katabella Roberts Retail sales in the United States were stronger than expected in March, driven, in part, by a...
Innovative Therapy Reverses Lung and Nerve Damage from COVID-19
By Jingduan Yang M.D. Many of us who have been infected with the COVID-19 virus face long-term health challenges, including lung...
Vehicle Affordability Improved to Best Level in 45 Months: Report
By Naveen Athrappully March was the best time for buying a car in more than three years in terms of...
Honda Shifting Production of Civic Hybrid to US From Japan
By Austin Alonzo Japanese automaker Honda Motor Co. will move its production of the five-door Civic hybrid model to Indiana...
Trump Signs Order Barring Illegal Immigrants From Receiving Social Security
By T.J. Muscaro President Donald Trump signed a memorandum on April 15 directing several federal agencies to take measures to...
Invesco Ltd. Grows Stake in Patterson-UTI Energy, Inc. (NASDAQ:PTEN)
Invesco Ltd. increased its position in Patterson-UTI Energy, Inc. (NASDAQ:PTEN – Free Report) by 27.8% during the fourth quarter, HoldingsChannel.com...